1. Home
  2. PRTA vs DNUT Comparison

PRTA vs DNUT Comparison

Compare PRTA & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • DNUT
  • Stock Information
  • Founded
  • PRTA 2012
  • DNUT 1937
  • Country
  • PRTA Ireland
  • DNUT United States
  • Employees
  • PRTA N/A
  • DNUT N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • DNUT Food Chains
  • Sector
  • PRTA Health Care
  • DNUT Consumer Staples
  • Exchange
  • PRTA Nasdaq
  • DNUT Nasdaq
  • Market Cap
  • PRTA 809.8M
  • DNUT 720.4M
  • IPO Year
  • PRTA N/A
  • DNUT 2021
  • Fundamental
  • Price
  • PRTA $9.70
  • DNUT $4.33
  • Analyst Decision
  • PRTA Buy
  • DNUT Buy
  • Analyst Count
  • PRTA 9
  • DNUT 7
  • Target Price
  • PRTA $54.57
  • DNUT $11.57
  • AVG Volume (30 Days)
  • PRTA 605.6K
  • DNUT 4.1M
  • Earning Date
  • PRTA 05-07-2025
  • DNUT 05-08-2025
  • Dividend Yield
  • PRTA N/A
  • DNUT 3.23%
  • EPS Growth
  • PRTA N/A
  • DNUT N/A
  • EPS
  • PRTA N/A
  • DNUT 0.02
  • Revenue
  • PRTA $135,157,000.00
  • DNUT $1,665,397,000.00
  • Revenue This Year
  • PRTA N/A
  • DNUT N/A
  • Revenue Next Year
  • PRTA $131.71
  • DNUT $9.87
  • P/E Ratio
  • PRTA N/A
  • DNUT $241.49
  • Revenue Growth
  • PRTA 47.92
  • DNUT N/A
  • 52 Week Low
  • PRTA $9.00
  • DNUT $3.91
  • 52 Week High
  • PRTA $25.42
  • DNUT $13.25
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 34.03
  • DNUT 38.92
  • Support Level
  • PRTA $9.00
  • DNUT $3.91
  • Resistance Level
  • PRTA $10.07
  • DNUT $4.58
  • Average True Range (ATR)
  • PRTA 0.74
  • DNUT 0.32
  • MACD
  • PRTA 0.07
  • DNUT 0.10
  • Stochastic Oscillator
  • PRTA 28.00
  • DNUT 57.93

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

Share on Social Networks: